Live from ASH 2024 First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with RR Ph ALL
| DNLYX Fund | USD 57.67 0.03 0.05% |
Slightly above 62% of Dreyfus Active's investor base is looking to short. The analysis of overall sentiment of trading Dreyfus Active Midcap mutual fund suggests that many investors are alarmed at this time. Dreyfus Active's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Active's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
Ascentage Pharma , a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released the safety and efficacy data of the companys novel drug candidate, olverembatinib , in combination the companys investigational novel Bcl-2 inhibitor, lisaftoclax , in children and adolescents with relapsedrefractory Philadelphia chromosomeposit
Read at finance.yahoo.com
 |
Dreyfus Active Fundamental Analysis
We analyze Dreyfus Active's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Active using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Active based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Dreyfus Active is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Dreyfus Active Midcap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Active mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Active could also be used in its relative valuation, which is a method of valuing Dreyfus Active by comparing valuation metrics with similar companies.
Peers
Dreyfus Active Related Equities
| PRVBX | Versatile Bond | 0.14 | ||||
| TRFJX | T Rowe | 0.19 | ||||
| VOLMX | Volumetric Fund | 0.21 | ||||
| OPTCX | Rbb Fund | 0.21 | ||||
| RGACX | Growth Fund | 0.66 | ||||
| JTSQX | Jp Morgan | 0.82 | ||||
| TMVAX | Rbc Microcap | 1.75 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Active financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Active security.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |